A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Teva- Pharmaceutical Industries Ltd. ADR’s current trading price is 0.18% away from its 52-week high, while its distance from the 52-week low is 114.80%. The stock’s price range for this time frame has been between $10.34 and $22.17. The trading volume of the company’s shares in the Healthcare reached around 11.77 million for the day, which was evidently higher than the average daily volume of 8.05 million over the last three months.
The stock market performance of Teva- Pharmaceutical Industries Ltd. ADR has been very steady. Over the last year, the company’s stock hit its highest at $22.17 on 12/23/24, while the lowest price during the same time frame was $10.34, recorded on 12/26/23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
How Financial Performance Impacts Market Capitalization
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has experienced a quarterly rise of 25.27% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 25.20B and boasts a workforce of 37226 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 17.87, with a change in price of +4.67. Similarly, Teva- Pharmaceutical Industries Ltd. ADR recorded 8,010,672 in trading volume during the last 100 days, posting a change of +26.62%.
How TEVA’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TEVA stands at 3.18. Similarly, the long-term debt-to-equity ratio is also 2.75.
TEVA Stock Stochastic Average
The raw stochastic average for Teva- Pharmaceutical Industries Ltd. ADR over the last 50 days is presently at 99.26%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 99.25%. Further, the company’s Stochastic %K and %D values for the last 20 days were 95.40% and 92.30%, respectively.
TEVA Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a gain of 112.74%.However, over the last six months, we can see a weaker performance of 34.61%. Over the last 30 days, the price of TEVA has fallen by 30.04%. And in the last five days, it has surged by 34.52%.
